Literature DB >> 35561748

Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health.

Guoyan Wang1, Lei Chen2, Senlin Qin1, Tingting Zhang3, Junhu Yao1, Yanglei Yi3,4, Lu Deng1.   

Abstract

Mechanistic target of rapamycin complex 1 (mTORC1) is a multi-protein complex widely found in eukaryotes. It serves as a central signaling node to coordinate cell growth and metabolism by sensing diverse extracellular and intracellular inputs, including amino acid-, growth factor-, glucose-, and nucleotide-related signals. It is well documented that mTORC1 is recruited to the lysosomal surface, where it is activated and, accordingly, modulates downstream effectors involved in regulating protein, lipid, and glucose metabolism. mTORC1 is thus the central node for coordinating the storage and mobilization of nutrients and energy across various tissues. However, emerging evidence indicated that the overactivation of mTORC1 induced by nutritional disorders leads to the occurrence of a variety of metabolic diseases, including obesity and type 2 diabetes, as well as cancer, neurodegenerative disorders, and aging. That the mTORC1 pathway plays a crucial role in regulating the occurrence of metabolic diseases renders it a prime target for the development of effective therapeutic strategies. Here, we focus on recent advances in our understanding of the regulatory mechanisms underlying how mTORC1 integrates metabolic inputs as well as the role of mTORC1 in the regulation of nutritional and metabolic diseases.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  mTORC1; metabolic diseases; metabolism; nutrient; signal transduction

Mesh:

Substances:

Year:  2022        PMID: 35561748      PMCID: PMC9526850          DOI: 10.1093/advances/nmac055

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   11.567


  217 in total

1.  Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients.

Authors:  Matt Kaeberlein; R Wilson Powers; Kristan K Steffen; Eric A Westman; Di Hu; Nick Dang; Emily O Kerr; Kathryn T Kirkland; Stanley Fields; Brian K Kennedy
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

2.  Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.

Authors:  Takeshi Kaizuka; Taichi Hara; Noriko Oshiro; Ushio Kikkawa; Kazuyoshi Yonezawa; Kenji Takehana; Shun-Ichiro Iemura; Tohru Natsume; Noboru Mizushima
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

Review 3.  Mechanistic Target of Rapamycin Is a Novel Molecular Mechanism Linking Folate Availability and Cell Function.

Authors:  Elena Silva; Fredrick J Rosario; Theresa L Powell; Thomas Jansson
Journal:  J Nutr       Date:  2017-06-07       Impact factor: 4.798

4.  regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis.

Authors:  Jae Eun Kim; Jie Chen
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

5.  Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb.

Authors:  Yong Li; Yian Wang; Eunjung Kim; Peter Beemiller; Cun-Yu Wang; Joel Swanson; Ming You; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2007-10-10       Impact factor: 5.157

6.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

Review 7.  The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway.

Authors:  Rachel L Wolfson; David M Sabatini
Journal:  Cell Metab       Date:  2017-08-01       Impact factor: 27.287

8.  Maternal folate deficiency causes inhibition of mTOR signaling, down-regulation of placental amino acid transporters and fetal growth restriction in mice.

Authors:  Fredrick J Rosario; Peter W Nathanielsz; Theresa L Powell; Thomas Jansson
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

9.  RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation.

Authors:  Tingting Li; Xian Wang; Enguo Ju; Suzane Ramos da Silva; Luping Chen; Xinquan Zhang; Shan Wei; Shou-Jiang Gao
Journal:  Nat Commun       Date:  2021-02-16       Impact factor: 14.919

10.  PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.

Authors:  Mark J Ranek; Kristen M Kokkonen-Simon; Anna Chen; Brittany L Dunkerly-Eyring; Miguel Pinilla Vera; Christian U Oeing; Chirag H Patel; Taishi Nakamura; Guangshuo Zhu; Djahida Bedja; Masayuki Sasaki; Ronald J Holewinski; Jennifer E Van Eyk; Jonathan D Powell; Dong Ik Lee; David A Kass
Journal:  Nature       Date:  2019-01-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.